Deep Track Capital’s Dianthus Therapeutics DNTH Stock Holding History

Deep Track Capital’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,233,148	Closed	-$41.6M	–	60
2025 Q2	$41.6M	Sell	2,233,148 -124,554	-5%	-$2.34M	1.33%	24
2025 Q1	$42.8M	Buy	+2,357,702	New	+$52M	1.38%	21
2023 Q1	–	Sell	-187,500	Closed	-$1.19M	–	65
2022 Q4	$1.19M	Sell	187,500 -147,438	-44%	-$2.61M	0.05%	58
2022 Q3	$7.56M	Hold	334,938	–	–	0.35%	57
2022 Q2	$6.43M	Hold	334,938	–	–	0.42%	41
2022 Q1	$15.5M	Buy	334,938 +30,563	+10%	+$1.67M	1%	29
2021 Q4	$21.6M	Buy	+304,375	New	+$30.6M	1.52%	27

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deep Track Capital's DNTH Position: Q3 2025 in Review

Deep Track Capital sold out of Dianthus Therapeutics (DNTH) in Q3 2025, closing a stake of 2,233,148 shares — an estimated $41.6M sold.

Deep Track Capital first reported a position in DNTH in Q4 2021 and held it in 7 quarters. The position peaked at $42.8M in Q1 2025. 140 funds tracked by Wall St. Rank hold DNTH as of Q3 2025.

Deep Track Capital reported no remaining Dianthus Therapeutics position as of Q3 2025 after selling out during the quarter.
Deep Track Capital sold 2,233,148 Dianthus Therapeutics shares in Q3 2025, an estimated $41.6M.
Deep Track Capital first reported a position in Dianthus Therapeutics in Q4 2021 and held it in 7 quarters.
Deep Track Capital's Dianthus Therapeutics position peaked at $42.8M in Q1 2025.
140 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2025.

Based on Deep Track Capital's 13F filing for Q3 2025, filed 14 Nov 2025.